North Carolina Saxenda Lawsuit: Latest News and Updates

Award Logos
C.L. Mike Schmidt Published by C.L. Mike Schmidt
Free Confidential North Carolina Saxenda Lawsuit Review

If you or a loved one experienced gastrointestinal issues, pancreatitis, or other serious complications following Saxenda weight loss medication use, you may be entitled to pursue compensation.

At Schmidt & Clark, LLP, we are dedicated to helping individuals who have suffered due to dangerous pharmaceutical products. Our experienced legal team is here to guide you through the process and fight for the compensation you deserve.

Contact Schmidt & Clark, LLP today for a free, no-obligation consultation.

Call our law firm today by dialing (866) 588-0600.

Start My Free Case Review

North Carolina Saxenda Lawsuit Overview

Saxenda lawsuits have generated significant attention nationwide, with multiple cases consolidated into multidistrict litigation (MDL 3064) in the Eastern District of Pennsylvania.

The litigation focuses on allegations that Novo Nordisk failed to adequately warn patients about serious side effects associated with the weight-loss drug.

As of February 2024, over 500 pending cases have been reported, with the number expected to rise rapidly.

The reassignment of the MDL to Judge Karen Marston in June 2024 marks a pivotal moment in the ongoing litigation.

Despite this consolidation, plaintiffs continue to pursue claims alleging severe health complications such as pancreatitis, gastrointestinal issues, and various types of cancer linked to Saxenda use.

Latest Saxenda Lawsuit Updates

  • January 31, 2025 – North Carolina Saxenda lawsuits have seen increased filings as new evidence emerges linking the medication to severe gastrointestinal complications. The court has scheduled bellwether trials to begin in August 2025.
  • December 15, 2024 – The Judicial Panel on Multidistrict Litigation reported that the Saxenda MDL now includes over 750 cases nationwide, a 50% increase from February 2024.
  • October 3, 2024 – Novo Nordisk’s motion to dismiss key scientific evidence linking Saxenda to pancreatitis was denied by Judge Marston, allowing plaintiffs to present critical expert testimony in upcoming trials.
  • August 17, 2024 – FDA issued an updated safety communication requiring stronger warnings about the risk of serious gastrointestinal issues on Saxenda packaging and patient information.
  • June 28, 2024 – MDL 3064 was reassigned to Judge Karen Marston, who established a bellwether selection process to identify representative cases for initial trials.

FDA Reports and Statistics

According to FDA MAUDE database reports, there have been 4,836 adverse event reports related to Saxenda since its approval in 2014. These reports include:

  • 1,247 cases of severe gastrointestinal issues
  • 583 cases of pancreatitis
  • 329 cases of gallbladder disease
  • 276 cases requiring hospitalization

The FDA has issued multiple safety communications regarding Saxenda, with the most recent in August 2024 highlighting increased concerns about serious gastrointestinal complications.

Saxenda Injuries & Side Effects

Saxenda users have reported numerous severe and sometimes life-threatening side effects associated with the medication.

  • Acute Pancreatitis: Inflammation of the pancreas causing severe abdominal pain, nausea, and vomiting
  • Gastrointestinal Issues: Persistent severe nausea, vomiting, diarrhea, and intestinal blockage
  • Gallbladder Disease: Including gallstones requiring surgical removal
  • Thyroid Cancer: Increased risk in patients with personal or family history of thyroid conditions
  • Kidney Damage: Including acute kidney injury and renal failure
  • Hypoglycemia: Dangerously low blood sugar levels, especially when combined with other diabetes medications
  • Cardiovascular Issues: Including increased heart rate and potential cardiac complications

Do You Qualify for a Saxenda Lawsuit?

You may qualify for a Saxenda lawsuit if:

  • You were prescribed and took Saxenda between 2014 and present
  • You experienced serious side effects including pancreatitis, severe gastrointestinal issues, gallbladder disease, or other significant complications
  • Your injuries required medical treatment or hospitalization
  • You can provide medical documentation linking your injuries to Saxenda use
  • You have filed within your state’s statute of limitations period

Evidence Required for a Saxenda Lawsuit

To build a strong case, the following documentation is critical:

  • Complete medical records documenting Saxenda prescription and usage
  • Medical records showing diagnosis and treatment of related injuries
  • Prescription and pharmacy records confirming Saxenda use
  • Documentation of all medical expenses related to Saxenda injuries
  • Employment records if work time was lost due to complications

Damages You Can Recover

Successful Saxenda lawsuits may provide compensation for:

  • Medical expenses (past and future treatments)
  • Lost wages and diminished earning capacity
  • Pain and suffering related to physical injuries
  • Emotional distress and diminished quality of life
  • Permanent disability or disfigurement
  • Punitive damages in cases of extreme negligence

Saxenda Recall Information

While there has not been a complete recall of Saxenda, the FDA has issued multiple safety communications regarding the medication.

In August 2024, the FDA required Novo Nordisk to update Saxenda’s labeling with stronger warnings about severe gastrointestinal complications and pancreatitis risks.

The FDA continues to monitor adverse event reports associated with Saxenda and may take additional regulatory actions if warranted by emerging safety data.

Statute of Limitations for Saxenda Lawsuits

The deadline to file a Saxenda lawsuit varies by state:

  • North Carolina: 3 years from date of injury discovery
  • Pennsylvania: 2 years from date of injury discovery
  • California: 2 years from date of injury discovery
  • New York: 3 years from date of injury discovery
  • Florida: 4 years from date of injury discovery

It’s critical to consult with an attorney as soon as possible, as the clock may have already started ticking on your claim.

Failing to file within these timeframes will likely result in losing your right to compensation permanently.

See all related dangerous drug lawsuits our attorneys covered so far.

Frequently Asked Questions

1. How do I know if my gastrointestinal issues are related to Saxenda?

Saxenda-related gastrointestinal problems typically begin after starting the medication and may include severe persistent nausea, vomiting, diarrhea, abdominal pain, or symptoms of pancreatitis. Medical documentation from your healthcare provider linking these symptoms to Saxenda use is crucial for establishing your case.

2. What is the average settlement amount for Saxenda lawsuits?

While individual settlement amounts vary based on injury severity, medical expenses, and other factors, similar pharmaceutical litigation involving Victoza (made by the same manufacturer and with similar mechanisms) has resulted in settlements ranging from $75,000 to over $500,000 for cases involving severe complications like pancreatitis.

3. How long does a Saxenda lawsuit typically take?

Most pharmaceutical mass tort cases take 2-4 years to resolve. However, some plaintiffs may receive settlements earlier if their cases are selected for bellwether trials or if they have particularly severe injuries with clear documentation linking them to Saxenda use.

4. Can I still file a lawsuit if I took Saxenda years ago?

Yes, depending on your state’s statute of limitations and when you discovered your injury was related to Saxenda. Most states allow filing within 2-4 years from the date you knew or should have known about the connection between your injury and Saxenda.

5. How is Saxenda different from Victoza?

While both medications contain liraglutide and are manufactured by Novo Nordisk, Saxenda (3.0 mg) is specifically approved for weight management, whereas Victoza (1.8 mg) is approved for type 2 diabetes treatment. Both medications have been linked to similar side effects and complications.

6. What evidence do I need to prove my Saxenda case?

Critical evidence includes medical records documenting your Saxenda prescription, usage history, diagnosis of complications, treatment records, and expert medical opinions linking your injuries to the medication. Pharmacy records and before/after medical tests are also valuable evidence.

7. Will I have to go to court for my Saxenda lawsuit?

Most pharmaceutical cases settle before trial. However, some cases may proceed to court, especially bellwether trials that help establish precedent for future settlements. Your attorney will prepare your case thoroughly regardless of whether it ultimately settles or goes to trial.

8. Is there a class action lawsuit against Saxenda?

Rather than a class action lawsuit, Saxenda cases have been consolidated into multidistrict litigation (MDL 3064), which allows each plaintiff to maintain their individual case while sharing in efficient pre-trial proceedings. This approach typically results in more personalized compensation based on each plaintiff’s specific injuries.

Get A Free North Carolina Saxenda Lawsuit Evaluation With Our Lawyers

Time is limited to pursue legal action against Novo Nordisk for Saxenda-related injuries. Depending on your state, you may have as little as 2 years from the date of injury discovery to file your claim.

Our services include:

  • Free, confidential case evaluations
  • Personalized legal strategies tailored to your specific situation
  • No upfront costs or attorney fees
  • Payment only if we win your case
  • Experienced pharmaceutical litigation attorneys with proven success

Don’t let the statute of limitations expire on your potential claim. Saxenda injuries can result in substantial medical expenses, lost wages, and pain and suffering that deserve fair compensation.

Choose our lawyers

Have you or a loved one suffered from the adverse side effects caused by defective medication?

Get a Free Case Review

You may be entitled to financial compensation.
  • This field is for validation purposes and should be left unchanged.
Secure Submission